CRP and COVID-19: More than 90% were with minimal symptoms or asymptomatic, with 2.0% required critical care support.[4] COVID-19 patients with existing comorbidities (mainly hypertensive and diabetes) had higher C-reactive protein (CRP) levels (inflammatory response), a higher ICU admission rate, extended hospitalization, and more oxygen use.[5,6] On the other hand, patients with eosinophilia had a lower level of CRP, milder clinical course and better disease outcomes compared to those without eosinophilia.[7]